NATF is pleased to partner with ScientiaCME to offer online continuing medical education programs. Please log in on the ScientiaCME website to enroll in courses and claim credits. If you don’t currently have a ScientiaCME login, you can sign up here.

New Strategies for the Treatment and Management of Anticoagulant Bleeding (Online Enduring)

Click Here to View Course Listing

ACTIVITY DESCRIPTION / STATEMENT OF NEED:

The content of this online activity was presented originally at a live event. It is divided into three videos. Learners must view all three in their entirety and complete a post-activity assessment and evaluation before they are eligible for continuing credit.

The North American Thrombosis Forum’s (NATF’s) “New Strategies for the Treatment and Management of Anticoagulant-Associated Bleeding” offers attendees insight into the most recent medical research and innovation in protecting patients at risk for anticoagulant-associated bleeding. The activity, taught by world thought leaders, will focus on educating healthcare providers who treat patients on—or who are a candidate for—anticoagulation. We welcome world-class experts in cardiology, hematology, vascular medicine, and pharmacy to update us on this challenging topic.

Although there are many new anticoagulants available, there are few advancements in how to manage and treat patients at risk for major bleeding. This program focuses on bleeding risks associated with DOACs and warfarin. Experts discuss novel approaches for managing bleeding risks in vulnerable patients, patients in need of a procedure, and best practices for anticoagulant treatment options. The program includes real-world patient cases and concludes with a discussion and Q&A.

TARGET AUDIENCE:

Physicians, pharmacists, nurses, physician assistants, and nurse practitioners who specialize in cardiology or hematology and any other health professional, patient, or family member with an interest in anticoagulant-associated bleeding.

LEARNING OBJECTIVES:

By the end of the session the participant will be able to:

  • Recall and define risk factors for perioperative thrombotic risk and anticoagulant-associated bleeding
  • List strategies to prevent or minimize anticoagulation-associated bleeding and apply them to patient cases
  • Summarize approaches to the management of bleeding and thrombotic risk in anticoagulated patients requiring invasive procedures
  • Describe when to use anticoagulation reversal agents

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: ScientiaCME designates this educational activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™ toward the AMA Physician’s Recognition Award. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Pharmacists: ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.25 hours (0.225 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. ACPE #0574-9999-20-003-H01-P. CPE credit effective 5/1/20 and expires 4/30/21.

This is a Knowledge (K)-type activity.

You must enter your NABP # and birth date correctly so that proof of participation can be posted to your NABP CPE profile. It is the learner’s responsibility to provide this information completely and accurately at the completion of the activity. Without providing it, the learner will NOT receive CPE credit for this activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Participation in this activity is made possible, free of charge, with the support of Portola Pharmaceuticals.

RELEASE DATE: May 01, 2020 — EXPIRATION DATE: April 30, 2021

AGENDA

VIDEO 1

Anticoagulant-Associated Bleeding: An Enemy Hiding in Plain Sight
Christian T. Ruff, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Director of General Cardiology Division, Brigham and Women’s Hospital, Boston, MA

Warfarin isn’t Going Away, and Neither is Warfarin-Associated Bleeding
Gregory Piazza, MD, MS
Associate Professor of Medicine, Harvard Medical School
Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA
VIDEO 2

The Blessing and Curse of Direct Oral Anticoagulants (DOACs): Management of DOAC-Associated Bleeding
Jean Connors, MD
Assistant Professor of Medicine, Harvard Medical School
Hematology Attending
Medical Director Hemostatic Antithrombotic Stewardship
Anticoagulation Management Services
Brigham and Women’s Hospital, Boston, MA

Critical Pathways for the Assessment of Anticoagulants in the Bleeding Patient
Nathan T. Connell, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Hematology Division, Brigham and Women’s Hospital, Boston, MA
VIDEO 3

My Patient is not Bleeding but Needs a Procedure
Umberto Campia, MD, MS
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital, Boston, MA

An Ounce of Prevention: Strategies for Safe Anticoagulation in Vulnerable Patients
Katelyn W. Sylvester, PharmD, CACP, BCPS
Pharmacy Manager – Anticoagulation Services
PGY1 Pharmacy Residency Coordinator, Department of Pharmacy
Brigham and Women’s Hospital, Boston, MA

Panel Discussion and Q&A

FACULTY DISCLOSURES AND RESOLUTION OF COI

Christian T. Ruff, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Director of General Cardiology Division, Brigham and Women’s Hospital, Boston, MA, discloses research/grant through institution: Boehringer Ingelheim, Daiichi Sankyo, MedImmune, National Institutes of Health; honoraria for scientific advisory boards and consulting: Bayer, Bristol Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Janssen, MedImmune, Pfizer, Portola, and Anthos.

Dr. Ruff is a member of the TIMI Study Group, which has received institutional research grant support through Brigham and Women’s Hospital from: Abbott, Amgen, Aralez, AstraZeneca, Bayer HealthCare Pharmaceuticals, Inc., BRAHMS, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen, MedImmune, Merck, Novartis, Pfizer, Poxel, Quark Pharmaceuticals, Roche, Takeda, The Medicines Company, and Zora Biosciences.

Gregory Piazza, MD, MS, Associate Professor of Medicine, Harvard Medical School; Staff Physician, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, discloses grant/research support from BMS, Portola, BTG/EKOS, Janssen, Bayer, and Daiichi-Sankyo and is a consultant for Pfizer, Amgen, and Thrombolex.

Jean Connors, MD, Assistant Professor of Medicine, Harvard Medical School; Hematology Attending, Medical Director Hemostatic Antithrombotic Stewardship and Anticoagulation Management Services, Brigham and Women’s Hospital, Boston, MA discloses being a consultant with Bristol-Myers Squibb, part of a scientific advisory board for Portola, and having received grant/research support from CSL Behring.

Nathan T. Connell, MD, MPH, Assistant Professor of Medicine, Harvard Medical School; Associate Physician, Hematology Division,  Brigham and Women’s Hospital, Boston, MA, has no conflicts of interest to disclose.

Umberto Campia, MD, MS, Assistant Professor of Medicine, Harvard Medical School, Associate Physician, Brigham and Women’s Hospital, Boston, MA, has no conflicts of interest to disclose.

Katelyn W. Sylvester, PharmD, CACP, BCPS, Pharmacy Manager – Anticoagulation Services; PGY1 Pharmacy Residency Coordinator, Department of Pharmacy, Brigham and Women’s Hospital, Boston, MA, discloses that she is a consultant for Portola Pharmaceuticals.

INSTRUCTIONS:

  • Read the learning objectives above.
  • Take the Pre-Test (optional). Completion of the pre-test will help us evaluate the knowledge gained by participating in this CME activity.
  • View the online activity. You may view this in more than one session, and may pause or repeat any portion of the presentation if you need to.
  • Take the post-test.
  • Complete the activity evaluation and CME registration. A CE certificate will be emailed to you immediately. 

SYSTEM REQUIREMENTS

PC

  • Windows 7 or above
  • Internet Explorer 8
  • *Adobe Acrobat Reader

*Required to view Printable PDF Version

MAC

  • Mac OS 10.2.8
  • Safari or Chrome or Firefox
  • *Adobe Acrobat Reader
  • Internet Explorer is not supported on the Macintosh